Need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

  • Email
  • Help
Current version

Concept paper

Reference numberEMA/CHMP/EWP/203111/2010
Published03/06/2010
KeywordsChronic immnune idiopathic thrombocytopenic purpura, ITP, thrombopoeting agonists
DescriptionThis document reflects the need for a guideline on the evaluation of the safety and efficacy of thrombopoetin receptor agonists fin the treatment of chronic immune (idiopathic) thrombocytopenic purpura. 

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more